期刊文献+

重庆地区儿童降钙素原生物参考区间的建立 被引量:4

Establishment of biology reference interval of PCT in children in Chongqing
下载PDF
导出
摘要 目的建立适用于重庆地区儿童的降钙素原(PCT)生物参考区间。方法招募120例健康儿童,男73例、女47例,年龄0~16岁,采用深圳新产业生物医学工程股份有限公司Maglumi2000plus型电化学发光法PCT检测系统及配套试剂盒检测血清PCT浓度。按照美国临床和实验室标准化协会EP28-A3c文件所规定的方法,分析并确定PCT生物参考区间。结果重庆地区健康儿童血清PCT水平呈偏态分布,不同性别、年龄儿童PCT水平比较差异无统计学意义(P>0.05);儿童PCT生物参考区间为PCT≤0.038μg/L。结论实验室应根据自有检测系统建立适合的生物参考区间。儿童作为特殊人群,更应单独建立相应的生物参考区间。 Objective To establish the biological reference interval of procalcitonin(PCT)applicable for children in Chongqing.Methods Serum PCT level were detected in 120 healthy children with age from 0 to 16 years,including 73 cases of male and 47 cases of female children,by using by Maglumi 2000 plus PCT analysis system.All data was evaluated according to EP28-A3 c document to establish the biological reference interval.Results Data of PCT levels were with non-normal distribution,and without statistical difference between children of different ages and genders(P〉0.05).The biological reference interval of PCT was less than or equal to 0.038μg/L.Conclusion It might be important to establish a usefully biological reference interval in different laboratories with relative detection system,especially for children.
出处 《国际检验医学杂志》 CAS 2017年第14期1935-1936,1939,共3页 International Journal of Laboratory Medicine
关键词 降钙素原 生物参考区间 儿童 procalcitonin biological reference interval children
  • 相关文献

参考文献2

二级参考文献125

  • 1Whang KT, Vath SD, Becker KL, et al. Procalcitonin and pro-inflammatory cytokine interactions in sepsis [ J]. Shock,2000,14(1): 73-78.
  • 2Nijsten MW, Olinga P, The TH,et al. Procalcitonin behaves as a fastresponding acute phase protein in vivo and in vitro [ J]. Crit Care Med, 2000, 28 (2): 458461.
  • 3Wiedermann FJ,Kaneider N,Egger P, et al. Migration of human monocytes in response to procalcitonin [J]. Crit Care Med, 2002 , 30(5): 1112-1117.
  • 4Hoffmann G, Totzke G, Seibel M, et al. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin [J]. Crit Care Med, 2001, 29 (1): 112-126.
  • 5Morgenthaler NG, Struck J, Chancerelle Y,et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection [J]. Horm Metab Res, 2003 , 35 ( 5): 290-295.
  • 6Meisner M, Tschaikowsky K, Schnabel S, et al. Procalcitonin- influence of temperature,storage,anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations [J]. EurJ Clin Chem Clin Biochem, 1997 , 35 ( 8): 597-601.
  • 7Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia [J]. Ann Emerg Med, 2008 , 52 (1): 48-58.
  • 8Kruger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes [J]. Eur Respir J,2008,31 (2): 349-355.
  • 9Hirakata Y,Yanagihara K, Kurihara S, et al. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia [J]. Diagn Microbiol Infect Dis, 2008 , 61 (2): 170-174.
  • 10Chan YL, Tseng CP, Tsay PK, et al. Procalcitonin as a marker of bacterial infection in the emergency department : an observational study[J]. Crit Care, 2(XM, 8 (1): R12-20.

共引文献670

同被引文献33

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部